The selection of MyoVista wavECG by the Innovation Value Institute and its upcoming demonstration at a high-profile event like the UN General Assembly is likely to boost investor confidence in Heart Test Laboratories. This recognition can lead to increased visibility and potential partnerships, positively impacting the stock price in the short term.